New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
11:23 EDTJNJVokanamet approved in the EU for treatment of adults with type 2 diabetes
Janssen-Cilag International NV announced that the European Commission has approved VOKANAMET in the European Union, for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control. Canagliflozin as a single agent was approved as INVOKANA in the European Union in November 2013. This EC decision follows a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency, recommending the approval of canagliflozin and immediate release metformin hydrochloride fixed dose combination therapy, in February. Janssen is a subsidiary of Johnson & Johnson.
News For JNJ From The Last 14 Days
Check below for free stories on JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
11:41 EDTJNJCubist rises after report sparks takeover interest speculation
Subscribe for More Information
August 12, 2014
09:35 EDTJNJActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
August 8, 2014
09:01 EDTJNJJohnson & Johnson remains undervalued, says Cowen
Subscribe for More Information
August 6, 2014
06:21 EDTJNJPiper Jaffray to hold a summit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use